Remodeling and reparation of the cardiovascular system

Department of Medicine, School of Medicine, University of Missouri-Columbia 65212.

Growth or altered metabolism of nonmyocyte cells (cardiac fibroblasts, vascular smooth muscle and endothelial cells) alters myocardial and vascular structure (remodeling) and function. However, the precise roles of circulating and locally generated factors such as angiotensin II, aldosterone and endothelin that regulate growth and metabolism of nonmyocyte cells have yet to be fully elucidated. Trials of pharmacologic therapy aimed at preventing structural remodeling and repairing altered myocardial structure to or toward normal in the setting of hypertension, heart failure and diabetes are reviewed. It is proposed that these are therapeutic goals that may reduce cardiovascular morbidity and mortality. Although this hypothesis remains unproved the primary goal of therapy should be to preserve or restore tissue structure and function.

This article has been cited by other articles:

				B. Drexler, C. Heinisch, C. Balmelli, J. Lassus, K. Siirila-Waris, N. Arenja, T. Socrates, M. Noveanu, M. Potocki, C. Meune, et al. Quantifying Cardiac Hemodynamic Stress and Cardiomyocyte Damage in Ischemic and Nonischemic Acute Heart Failure Circ Heart Fail, January 1, 2012; 5(1): 17 - 24. [Abstract] [Full Text] [PDF]

				C.-C. Chen, Y.-J. Hsu, and T.-M. Lee Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia Am J Physiol Heart Circ Physiol, September 1, 2011; 301(3): H1107 - H1117. [Abstract] [Full Text] [PDF]

				C.-C. Chen, H.-Y. Lien, Y.-J. Hsu, C.-C. Lin, C.-M. Shih, and T.-M. Lee Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43 J Appl Physiol, August 1, 2010; 109(2): 541 - 552. [Abstract] [Full Text] [PDF]

				E. M. Kanoupakis, E. G. Manios, E. M. Kallergis, H. E. Mavrakis, C. A. Goudis, I. G. Saloustros, M. E. Milathianaki, G. I. Chlouverakis, and P. E. Vardas Serum Markers of Collagen Turnover Predict Future Shocks in Implantable Cardioverter-Defibrillator Recipients With Dilated Cardiomyopathy on Optimal Treatment J. Am. Coll. Cardiol., June 15, 2010; 55(24): 2753 - 2759. [Abstract] [Full Text] [PDF]

				A. P. Dalla Costa, C. F. M. Z. Clemente, H. F. Carvalho, J. B. Carvalheira, W. Nadruz Jr, and K. G. Franchini FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex Cardiovasc Res, June 1, 2010; 86(3): 421 - 431. [Abstract] [Full Text] [PDF]

				T.-M. Lee, P.-Y. Lai, and N.-C. Chang Effect of N-acetylcysteine on sympathetic hyperinnervation in post-infarcted rat hearts Cardiovasc Res, January 1, 2010; 85(1): 137 - 146. [Abstract] [Full Text] [PDF]

				E. M. Kanoupakis, E. G. Manios, and P. E. Vardas Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers Europace, November 1, 2009; 11(11): 1434 - 1439. [Abstract] [Full Text] [PDF]

				G. Takemura, M. Nakagawa, H. Kanamori, S. Minatoguchi, and H. Fujiwara Benefits of reperfusion beyond infarct size limitation Cardiovasc Res, July 15, 2009; 83(2): 269 - 276. [Abstract] [Full Text] [PDF]

				S. W.M. van den Borne, S. Isobe, H. R. Zandbergen, P. Li, A. Petrov, N. D. Wong, S. Fujimoto, A. Fujimoto, D. Lovhaug, J. F.M. Smits, et al. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 187 - 198. [Abstract] [Full Text] [PDF]

				S. V. Chatzikyriakou, D. N. Tziakas, G. K. Chalikias, D. A. Stakos, A. K. Thomaidi, K. Mitrousi, A. E. Lantzouraki, S. Kotsiou, E. Maltezos, and H. Boudoulas Serum levels of collagen type-I degradation markers are associated with vascular stiffness in chronic heart failure patients Eur J Heart Fail, December 1, 2008; 10(12): 1181 - 1185. [Abstract] [Full Text] [PDF]

				W. H. W. Tang, W. Mullens, A. G. Borowski, W. Tong, K. Shrestha, R. W. Troughton, M. G. Martin, K. Kassimatis, D. Agler, S. Jasper, et al. Relation of mechanical dyssynchrony with underlying cardiac structure and performance in chronic systolic heart failure: implications on clinical response to cardiac resynchronization Europace, December 1, 2008; 10(12): 1370 - 1374. [Abstract] [Full Text] [PDF]

				T.-M. Lee, M.-S. Lin, and N.-C. Chang Effect of ATP-Sensitive Potassium Channel Agonists on Ventricular Remodeling in Healed Rat Infarcts J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1309 - 1318. [Abstract] [Full Text] [PDF]

				F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]

				D. N. Tziakas, G. K. Chalikias, N. Papanas, D. A. Stakos, S. V. Chatzikyriakou, and E. Maltezos Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation Europace, August 1, 2007; 9(8): 589 - 596. [Abstract] [Full Text] [PDF]

				M.S. Kostapanos, E.N. Liberopoulos, J.A. Goudevenos, D.P. Mikhailidis, and M.S. Elisaf Do statins have an antiarrhythmic activity? Cardiovasc Res, July 1, 2007; 75(1): 10 - 20. [Abstract] [Full Text] [PDF]

				A. Radauceanu, F. Moulin, W. Djaballah, P. Y. Marie, F. Alla, B. Dousset, J. M. Virion, J. Capiaumont, G. Karcher, E. Aliot, et al. Residual stress ischaemia is associated with blood markers of myocardial structural remodelling Eur J Heart Fail, April 1, 2007; 9(4): 370 - 376. [Abstract] [Full Text] [PDF]

				T.-M. Lee, M.-S. Lin, T.-F. Chou, and N.-C. Chang Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1281 - H1289. [Abstract] [Full Text] [PDF]

				G.-Y. Wang, M. R. Bergman, A. P. Nguyen, S. Turcato, P. M. Swigart, M. C. Rodrigo, P. C. Simpson, J. S. Karliner, D. H. Lovett, and A. J. Baker Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility Cardiovasc Res, February 15, 2006; 69(3): 688 - 696. [Abstract] [Full Text] [PDF]

				T. Iwasaki, K. Mukasa, M. Yoneda, S. Ito, Y. Yamada, Y. Mori, N. Fujisawa, T. Fujisawa, K. Wada, H. Sekihara, et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1222 - E1228. [Abstract] [Full Text] [PDF]

				R. Ramani, M. Mathier, P. Wang, G. Gibson, S. Togel, J. Dawson, A. Bauer, S. Alber, S. C. Watkins, C. F. McTiernan, et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1369 - H1377. [Abstract] [Full Text] [PDF]

				K. Yamamoto, Y. Takahashi, T. Mano, Y. Sakata, N. Nishikawa, J. Yoshida, Y. Oishi, M. Hori, T. Miwa, S. Inoue, et al. N-Methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism Eur. Heart J., July 2, 2004; 25(14): 1221 - 1229. [Abstract] [Full Text] [PDF]

				R. E. Chapman and F. G. Spinale Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H1 - H10. [Full Text] [PDF]

				E. J. Eichhorn, P. A. Grayburn, S. A. Mayer, M. St John Sutton, C. Appleton, J. Plehn, J. Oh, B. Greenberg, A. DeMaria, R. Frantz, et al. Myocardial Contractile Reserve by Dobutamine Stress Echocardiography Predicts Improvement in Ejection Fraction With {beta}-Blockade in Patients With Heart Failure: The {beta}-Blocker Evaluation of Survival Trial (BEST) Circulation, November 11, 2003; 108(19): 2336 - 2341. [Abstract] [Full Text] [PDF]

				M. Epstein Aldosterone receptor blockade and the role of eplerenone: evolving perspectives Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1984 - 1992. [Full Text] [PDF]

				B. I. Jugdutt Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix: When Is Enough Enough? Circulation, September 16, 2003; 108(11): 1395 - 1403. [Full Text] [PDF]

				A. Abbate, G. G. L. Biondi-Zoccai, R. Bussani, A. Dobrina, D. Camilot, F. Feroce, R. Rossiello, F. Baldi, F. Silvestri, L. M. Biasucci, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure J. Am. Coll. Cardiol., March 5, 2003; 41(5): 753 - 760. [Abstract] [Full Text] [PDF]

				N. Nishikawa, K. Yamamoto, Y. Sakata, T. Mano, J. Yoshida, T. Miwa, H. Takeda, M. Hori, and T. Masuyama Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation Cardiovasc Res, March 1, 2003; 57(3): 766 - 774. [Abstract] [Full Text] [PDF]

				C-M Yu, H Lin, Q Zhang, and J E Sanderson High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration Heart, January 1, 2003; 89(1): 54 - 60. [Abstract] [Full Text] [PDF]

				B. Schwartzkopff, M. Fassbach, B. Pelzer, M. Brehm, and B. E. Strauer Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy Eur J Heart Fail, August 1, 2002; 4(4): 439 - 444. [Abstract] [Full Text] [PDF]

				B. I. Jugdutt and V. Menon Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107. [Abstract] [PDF]

				F. G. Spinale Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart Circ. Res., March 22, 2002; 90(5): 520 - 530. [Abstract] [Full Text] [PDF]

				F. Bouzegrhane and G. Thibault Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res, February 1, 2002; 53(2): 304 - 312. [Abstract] [Full Text] [PDF]

				M. Epstein Aldosterone as a determinant of cardiovascular and renal dysfunction J R Soc Med, January 8, 2001; 94(8): 378 - 383. [Full Text] [PDF]

				T. Matsumoto, R. Ozono, T. Oshima, H. Matsuura, T. Sueda, G. Kajiyama, and M. Kambe Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure Cardiovasc Res, April 1, 2000; 46(1): 73 - 81. [Abstract] [Full Text] [PDF]

				T. Mishima, M. Tanimura, G. Suzuki, A. Todor, V. G. Sharov, S. Goldstein, and H. N. Sabbah Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure J. Am. Coll. Cardiol., January 1, 2000; 35(1): 222 - 229. [Abstract] [Full Text] [PDF]

				Y. Nagatomo, B. A. Carabello, M. L. Coker, P. J. McDermott, S. Nemoto, M. Hamawaki, and F. G. Spinale Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H151 - H161. [Abstract] [Full Text] [PDF]

				J. H. McElmurray III, R. Mukherjee, R. B. New, A. C. Sampson, M. K. King, J. W. Hendrick, A. Goldberg, T. J. Peterson, H. Hallak, M. R. Zile, et al. Angiotensin-Converting Enzyme and Matrix Metalloproteinase Inhibition with Developing Heart Failure: Comparative Effects on Left Ventricular Function and Geometry J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 799 - 811. [Abstract] [Full Text]

				A. Anvari, Z. Turel, A. Schmidt, N. Yilmaz, G. Mayer, K. Huber, E. Schuster, and M. Gottsauner-Wolf Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias Cardiovasc Res, September 1, 1999; 43(4): 879 - 883. [Abstract] [Full Text] [PDF]

				F. G. Spinale, M. L. Coker, S. R. Krombach, R. Mukherjee, H. Hallak, W. V. Houck, M. J. Clair, S. B. Kribbs, L. L. Johnson, J. T. Peterson, et al. Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure : Effects on Left Ventricular Dimensions and Function Circ. Res., August 20, 1999; 85(4): 364 - 376. [Abstract] [Full Text] [PDF]

				B Schwartzkopff and B.E Strauer Squeezing tubes: a case of remodeling and regulation: Coronary reserve in hypertensive heart disease Cardiovasc Res, October 1, 1998; 40(1): 4 - 8. [Full Text] [PDF]

				A. T. Armstrong, P. F. Binkley, P. B. Baker, P. D. Myerowitz, and C. V. Leier Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation J. Am. Coll. Cardiol., September 1, 1998; 32(3): 704 - 710. [Abstract] [Full Text] [PDF]

				S. M. Dodge, M. A. Beardslee, B. J. Darrow, K. G. Green, E. C. Beyer, and J. E. Saffitz Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes J. Am. Coll. Cardiol., September 1, 1998; 32(3): 800 - 807. [Abstract] [Full Text] [PDF]

				I. J. Benjamin and D. R. McMillan Stress (Heat Shock) Proteins : Molecular Chaperones in Cardiovascular Biology and Disease Circ. Res., July 27, 1998; 83(2): 117 - 132. [Abstract] [Full Text] [PDF]

				C. V. Thomas, M. L. Coker, J. L. Zellner, J. R. Handy, A. J. Crumbley III, and F. G. Spinale Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy Circulation, May 5, 1998; 97(17): 1708 - 1715. [Abstract] [Full Text] [PDF]

				F. G. Spinale, M. L. Coker, C. V. Thomas, J. D. Walker, R. Mukherjee, and L. Hebbar Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure : Relation to Ventricular and Myocyte Function Circ. Res., March 9, 1998; 82(4): 482 - 495. [Abstract] [Full Text] [PDF]

				H. Senzaki, Y. A. Gluzband, P. H. Pak, M. T. Crow, J. S. Janicki, and D. A. Kass Synergistic Exacerbation of Diastolic Stiffness From Short-term Tachycardia Induced Cardiodepression and Angiotensin II Circ. Res., March 9, 1998; 82(4): 503 - 512. [Abstract] [Full Text] [PDF]

				K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]

				F. G. Spinale, M. de Gasparo, S. Whitebread, L. Hebbar, M. J. Clair, D. M. Melton, R. S. Krombach, R. Mukherjee, J. P. Iannini, and S.-J. O Modulation of the Renin-Angiotensin Pathway Through Enzyme Inhibition and Specific Receptor Blockade in Pacing-Induced Heart Failure : I. Effects on Left Ventricular Performance and Neurohormonal Systems Circulation, October 7, 1997; 96(7): 2385 - 2396. [Abstract] [Full Text]

				R. J MacFadyen, C. S Barr, and A. D Struthers Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients Cardiovasc Res, July 1, 1997; 35(1): 30 - 34. [Abstract] [Full Text] [PDF]

				F. G. Spinale, J. D. Walker, R. Mukherjee, J. P. Iannini, A. T. Keever, and K. P. Gallagher Concomitant Endothelin Receptor Subtype-A Blockade During the Progression of Pacing-Induced Congestive Heart Failure in Rabbits : Beneficial Effects on Left Ventricular and Myocyte Function Circulation, April 1, 1997; 95(7): 1918 - 1929. [Abstract] [Full Text]

				R. J. Wiesner, H. Ehmke, J. Faulhaber, R. Zak, and J. C. Ruegg Dissociation of Left Ventricular Hypertrophy, -Myosin Heavy Chain Gene Expression, and Myosin Isoform Switch in Rats After Ascending Aortic Stenosis Circulation, March 4, 1997; 95(5): 1253 - 1259. [Abstract] [Full Text]

				E. J. Eichhorn and M. R. Bristow Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure Circulation, November 1, 1996; 94(9): 2285 - 2296. [Abstract] [Full Text]

				C. G. Brilla, L. Matsubara, and K. T. Weber Advanced Hypertensive Heart Disease in Spontaneously Hypertensive Rats: Lisinopril-Mediated Regression of Myocardial Fibrosis Hypertension, August 1, 1996; 28(2): 269 - 275. [Abstract] [Full Text]

				C.-P. Cheng, M. Suzuki, N. Ohte, M. Ohno, Z.-M. Wang, and W. C. Little Altered Ventricular and Myocyte Response to Angiotensin II in Pacing-Induced Heart Failure Circ. Res., May 1, 1996; 78(5): 880 - 892. [Abstract] [Full Text]

				W. Motz and B. E. Strauer Improvement of Coronary Flow Reserve After Long-term Therapy With Enalapril Hypertension, May 1, 1996; 27(5): 1031 - 1038. [Abstract] [Full Text]

				A. Ito, K. Egashira, T. Kadokami, Y. Fukumoto, T. Takayanagi, R. Nakaike, T. Kuga, K. Sueishi, H. Shimokawa, and A. Takeshita Chronic Inhibition of Endothelium-Derived Nitric Oxide Synthesis Causes Coronary Microvascular Structural Changes and Hyperreactivity to Serotonin in Pigs Circulation, November 1, 1995; 92(9): 2636 - 2644. [Abstract] [Full Text]

				F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, R. B. Hird, J. D. Walker, A. Arnim-Barker, J. R. Powell, and W. H. Koster Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy : Effects on Left Ventricular and Myocyte Structure and Function Circulation, August 1, 1995; 92(3): 562 - 578. [Abstract] [Full Text]

				V. Regitz-Zagrosek, N. Friedel, A. Heymann, P. Bauer, M. Neu, A. Rolfs, C. Steffen, A. Hildebrandt, R. Hetzer, and E. Fleck Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts Circulation, March 1, 1995; 91(5): 1461 - 1471. [Abstract] [Full Text]

				W. Motz, S. Scheler, B. Schwartzkopff, and B. E. Strauer Evaluation of Cardiac Damage in Hypertension European Journal of Cardiovascular Prevention & Rehabilitation, February 1, 1995; 2(1): 16 - 26. [Abstract] [PDF]